PRESS RELEASE, September 23, 2019

Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma Oral Presentation at the 13th Annual Conference of the International Liver Cancer Association Highlights Promising Antitumor Activity in...

PRESS RELEASE, September 16, 2019

Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer AssociationOral Presentation to Highlight Promising Preclinical Activity of...

PRESS RELEASE, September 12, 2019

Auransa Announces CEO to Participate on Executive Leadership Panel at the 6th Annual Indy Big Data Conference PALO ALTO, CA – September 12, 2019 – Auransa Inc., an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of...